Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Onconova Therapeutics Company Profile (NASDAQ:ONTX)

Consensus Ratings for Onconova Therapeutics (NASDAQ:ONTX) (?)
Ratings Breakdown: 2 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $10.33 (158.98% upside)

Analysts' Ratings History for Onconova Therapeutics (NASDAQ:ONTX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
8/14/2014Leerink SwannLower Price TargetOutperform$14.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
2/20/2014Leerink SwannLower Price Target$37.00 -> $14.00ViewTweet This Rating  Share This Rating on StockTwits
2/20/2014Janney Montgomery ScottDowngradeBuy -> Neutral$40.00 -> $10.00ViewTweet This Rating  Share This Rating on StockTwits
2/20/2014Piper JaffrayDowngradeOverweight -> Neutral$38.00 -> $9.00ViewTweet This Rating  Share This Rating on StockTwits
10/29/2013Citigroup Inc.UpgradeNeutral -> Buy$30.00 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
8/19/2013Leerink SwannInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
8/19/2013Piper JaffrayInitiated CoverageOverweight -> Overweight$38.00ViewTweet This Rating  Share This Rating on StockTwits
8/19/2013Janney Montgomery ScottInitiated CoverageBuy$40.00ViewTweet This Rating  Share This Rating on StockTwits
8/19/2013Citigroup Inc.Initiated CoverageNeutral$30.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/20/2012 forward)